Navigation Links
Irving Dark Named Vice President of Cytel Clinical Research Services
Date:1/16/2008

Proven Executive Brings Both Clinical Trial Experience and Business

Development Leadership to Clinical Trial Services Management Role

CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Cytel, Inc. announced today that clinical research and business development executive Irving Dark has accepted the role of Vice President of Cytel Clinical Research Services. Mr. Dark brings to Cytel 15-years of management experience guiding drug, biologic and medical device products successfully through the development process as well as growing commercial clinical research organizations.

In his new position, Mr. Dark will head and drive the growth of Cytel's cutting-edge clinical trial design and implementation services to the biopharmaceutical industry.

Prior to joining Cytel, Mr. Dark was Vice President, Business Development and Operations for Veristat, Inc. During his tenure he established and oversaw the company's Data Management, Project Management, and Business Development departments. Mr. Dark was integrally involved with Veristat's Corporate Compliance activities to ensure adherence with regulatory and GCP guidelines, and was instrumental in the company's oncology and influenza contracts, and the Acambis smallpox vaccine program.

Previously, Mr. Dark held several key positions at full-service trial leader PAREXEL, rising from statistical programming management to overseeing the planning and conduct of phase 1, 2, and 3 global clinical trials.

"Irving's experience in trial management and his knowledge of the clinical development needs of the biopharmaceutical industry are ideally suited to growing Cytel's innovative clinical research services" said Ranganath Nayak, Chief Executive Officer of Cytel.

"Cytel has an impressive track record delivering innovative solutions to the biopharmaceutical industry," said Irving Dark. "Cytel's experience designing innovative clinical trials and its advanced analytical capabilities differentiate
'/>"/>

SOURCE Cytel Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Panacea Pharmaceuticals Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazines Ten Biggest Medical Breakthroughs of 2007
2. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
3. Kent Riddle Named To Piedmont Triad Biotechnology Development Group
4. Deloitte Chairman of the Board Sharon L. Allen Named Chairman of the American Friends of the Phelophepa Train
5. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
6. K-States Subbaratnam Muthukrishnan and Barbara Valent Named Fellows of the American Association for the Advancement of Science
7. Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry
8. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
9. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
10. DuPont Named Among Top Biotechnology Employers by Science Magazine
11. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...all/ -- American,HealthChoice, Inc. (Pink Sheets:...medical services company with medical clinics in T...rst sales of the U.S. FDA approved OmniBody Scan, ...atterns of abnormality within,the human body and ...d,treatment. , "Physicians purchasing thes...
(Date:11/19/2008)...-FirstCall/ -- Bavarian Nordic,has invoiced the U...SD 25,million as allowed under the RFP-3 contract...he company,s IMVAMUNE(R) smallpox vaccine. This mi...ssion of a clinical safety report,from a large Ph...ects, which,is part of the regulatory package tha...
(Date:11/19/2008)...Therapeutics Inc., a,privately-held biotechnology...,hydrolase (s-EH) inhibitors, today announced tha... financing. Frazier Healthcare Ventures and Alta,...lso included existing,investors Burrill & Com...ce,Ventures. This financing completes the Series...
(Date:11/19/2008)...ociates Architects,( http://www.kornberg.com ) ha...,retained by the Okinawa Institute for Science an...nt funded scientific research campus and graduate,...made the announcement. , "Having a presence...solidifies our international capabilities," said K...
Breaking Biology Technology:American HealthChoice Announces the First Sales of the OmniBody Scan 2Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities 2Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing 2Kornberg Associates Architects Opens Tokyo Office 2
...income of $113.5 million during the first quarter ...rising 11 percent over the same quarter in 2006. ,...for the financial services industry, said net inco...e same quarter of 2006, but earnings per share wer...-month period. , ,Fiserv saw revenues grow to $1.2...
...nsin-Madison professor who has been called the fa...o operate a research lab as an adjunct professor a...,The Santa Barbara Independent is reporting th...t UW-Madison, will be in Santa Barbara about one m... team of four postdoctoral researchers. , ,The Ind...
...tt Laboratories story regarding its Kaletra AIDS ...and over patent protection and drug pricing. Some ...ff between a single drug company and another devel...l - if not the central - problem facing the ph... - regard this to be one of the most important iss...
...Corp . has given Northwestern Mutual Life some c... outside the life-science realm, that is. Inside t..., it,s anything but silent, as a constant churn of... has produced about 200 patents and more than 1,50...ovations since 2002. , ,That pace has resulted in ...
Other Biology Technology:Jamie Thomson to run California research lab 2Abbott vs. Thailand has implications for innovation and access 2Abbott vs. Thailand has implications for innovation and access 3Abbott vs. Thailand has implications for innovation and access 4Abbott vs. Thailand has implications for innovation and access 5Abbott vs. Thailand has implications for innovation and access 6Abbott vs. Thailand has implications for innovation and access 7Promega Corporation: Wisconsin's quiet innovator 2Promega Corporation: Wisconsin's quiet innovator 3Promega Corporation: Wisconsin's quiet innovator 4Promega Corporation: Wisconsin's quiet innovator 5
(Date:11/19/2008)...ery day brings news of an apparent breakthrough ag...nditions like diabetes, but these rarely translate...ey do clinical development usually takes well over...conducted in highly fragmented groups focusing on ...hat turn out not to work properly or to have dange...
(Date:11/19/2008)... compounds created by a University of Central Flor...east cancer tumors. , Associate Professor James ...ad of breast cancer tumors in tests on mice. The ...r-causing protein called STAT3, and researchers ha...The compounds are very promising," Turkson said. "...
(Date:11/18/2008)...Va., Nov. 18 Stanley, In...integration and professional,services to the U.S....art of a,team led by Science Applications Interna...year, cost-plus-fixed-fee task order valued at up ...xercised. With this award, the team will continue,...
(Date:11/18/2008)...HResearchers at the University of Pittsburgh have ...mercury in fish and dental samples, two substances...tamination. The technique involves a fluorescent s...o contact with oxidized mercury, the researchers r...l of the American Chemical Society . The intensity...
Breaking Biology News(10 mins):Systems biology brings hope of speeding up drug development 2Systems biology brings hope of speeding up drug development 3Two new compounds show promise for eliminating breast cancer tumors 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 3Pitt researchers use fluorescence to develop method for detecting mercury in fish 2TFAH Urges Congress to Override Presidents Veto of Labor HHS Appropriations 6377 1Dragon Sells EPO Business 3B Focus on Antibiotic Core Business 6372 1Dragon Sells EPO Business 3B Focus on Antibiotic Core Business 6372 2AUDIO from Medialink and the Canned Food Alliance 3A A Thanksgiving Bounty in Your Pantry 6367 1ClearWay Minnesota 28SM 29 to Share Stories of Real Minnesotans Who Used QUITPLAN 28R 29 Services During Great American Smokeout 6362 1ClearWay Minnesota 28SM 29 to Share Stories of Real Minnesotans Who Used QUITPLAN 28R 29 Services During Great American Smokeout 6362 2
...ks in humans in forests between Gabon and the Repu... wild animal carcasses, according to a study by th...onal partners. Appearing in the February edition o...udy found that many animal carcasses tested for Eb...s, and found direct links between the deadly disea...
...ests, new research indicates that it may all come ... University scientists who had previously identifi...fruit flies now shows that this gene,s function ap...ifferent insect species. , Research by Leslie Voss...odorant-receptor proteins expressed by fruit flies...
...developing a,vaccine against HIV infection have be...day of the Global HIV/AIDS Vaccine Enterprise,s,sc...reely available,open-access global health journal...rise is an international alliance of,independent a... HIV,vaccine research. In June 2004, the G8 countr...
...eurons in the,brain as a treatment for Parkinson d...ears ago, however the field is still in its infanc...n that,dopamine-producing neurons (DA neurons) gen...lanted into areas of the brain where these neurons...isease, can reverse,parkinsonism. Their results ap...
Other Biology News:Study Links Ebola Outbreaks To Animal Carcasses 2Ancient olfaction protein is shared by many bugs, offering new pest control target 2A much-needed shot in the arm for HIV vaccine development 2A much-needed shot in the arm for HIV vaccine development 3Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates 2